leisure time -WSS

leisure time

author：entertainment 2025-08-26 19:37:07 - browse：69383

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： $1 billion proposal to grow Boston, Massachusetts biotech

WSS

Health care court cases: Humana, Sutter, Novant

Cheap, fast test for Zika and dengue could cost just $1

Cheap, fast test for Zika and dengue could cost just $1

My daughter's legacy lives on through her writing, phage therapy

IVF doctors demand details after CooperSurgical lawsuit

A new approach to psychiatric drug development

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Cheap, fast test for Zika and dengue could cost just $1

In age of alternative facts, a scholarly course on calling out crap

ALS patient reclaims some autonomy thanks to wearable 'robot'

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A new approach to psychiatric drug development

Drug repurposing or repositioning? The language matters

First over

Affirmative action in medical school literally saved lives

Microsoft's Peter Lee: Generative AI could help doctors be more human

knowledge

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Pharma companies must ensure equitable access to obesity drugs

Lack of health data on LGBTQ+ people has serious consequences

Curing rare childhood diseases will falter unless Congress steps up

Statins may not be needed by millions of people, study suggests

Coercive sterilizations revealed by STAT prompt outrage

leisure time

focus

hotspot

focus